| Chapter 253 |
| 2023 -- S 0290 SUBSTITUTE A AS AMENDED Enacted 06/22/2023 |
| A N A C T |
| RELATING TO STATE AFFAIRS AND GOVERNMENT -- THE RHODE ISLAND HEALTH CARE REFORM ACT OF 2004 -- HEALTH INSURANCE OVERSIGHT |
Introduced By: Senators DiMario, Pearson, LaMountain, Miller, Valverde, Lauria, Lawson, Murray, Euer, and Ujifusa |
| Date Introduced: February 16, 2023 |
| It is enacted by the General Assembly as follows: |
| SECTION 1. Section 42-14.5-3 of the General Laws in Chapter 42-14.5 entitled "The |
| Rhode Island Health Care Reform Act of 2004 — Health Insurance Oversight" is hereby amended |
| to read as follows: |
| 42-14.5-3. Powers and duties. |
| The health insurance commissioner shall have the following powers and duties: |
| (a) To conduct quarterly public meetings throughout the state, separate and distinct from |
| rate hearings pursuant to § 42-62-13, regarding the rates, services, and operations of insurers |
| licensed to provide health insurance in the state; the effects of such rates, services, and operations |
| on consumers, medical care providers, patients, and the market environment in which the insurers |
| operate; and efforts to bring new health insurers into the Rhode Island market. Notice of not less |
| than ten (10) days of the hearing(s) shall go to the general assembly, the governor, the Rhode Island |
| Medical Society, the Hospital Association of Rhode Island, the director of health, the attorney |
| general, and the chambers of commerce. Public notice shall be posted on the department’s website |
| and given in the newspaper of general circulation, and to any entity in writing requesting notice. |
| (b) To make recommendations to the governor and the house of representatives and senate |
| finance committees regarding healthcare insurance and the regulations, rates, services, |
| administrative expenses, reserve requirements, and operations of insurers providing health |
| insurance in the state, and to prepare or comment on, upon the request of the governor or |
| chairpersons of the house or senate finance committees, draft legislation to improve the regulation |
| of health insurance. In making the recommendations, the commissioner shall recognize that it is |
| the intent of the legislature that the maximum disclosure be provided regarding the reasonableness |
| of individual administrative expenditures as well as total administrative costs. The commissioner |
| shall make recommendations on the levels of reserves, including consideration of: targeted reserve |
| levels; trends in the increase or decrease of reserve levels; and insurer plans for distributing excess |
| reserves. |
| (c) To establish a consumer/business/labor/medical advisory council to obtain information |
| and present concerns of consumers, business, and medical providers affected by health insurance |
| decisions. The council shall develop proposals to allow the market for small business health |
| insurance to be affordable and fairer. The council shall be involved in the planning and conduct of |
| the quarterly public meetings in accordance with subsection (a). The advisory council shall develop |
| measures to inform small businesses of an insurance complaint process to ensure that small |
| businesses that experience rate increases in a given year may request and receive a formal review |
| by the department. The advisory council shall assess views of the health provider community |
| relative to insurance rates of reimbursement, billing, and reimbursement procedures, and the |
| insurers’ role in promoting efficient and high-quality health care. The advisory council shall issue |
| an annual report of findings and recommendations to the governor and the general assembly and |
| present its findings at hearings before the house and senate finance committees. The advisory |
| council is to be diverse in interests and shall include representatives of community consumer |
| organizations; small businesses, other than those involved in the sale of insurance products; and |
| hospital, medical, and other health provider organizations. Such representatives shall be nominated |
| by their respective organizations. The advisory council shall be co-chaired by the health insurance |
| commissioner and a community consumer organization or small business member to be elected by |
| the full advisory council. |
| (d) To establish and provide guidance and assistance to a subcommittee (“the professional- |
| provider-health-plan work group”) of the advisory council created pursuant to subsection (c), |
| composed of healthcare providers and Rhode Island licensed health plans. This subcommittee shall |
| include in its annual report and presentation before the house and senate finance committees the |
| following information: |
| (1) A method whereby health plans shall disclose to contracted providers the fee schedules |
| used to provide payment to those providers for services rendered to covered patients; |
| (2) A standardized provider application and credentials verification process, for the |
| purpose of verifying professional qualifications of participating healthcare providers; |
| (3) The uniform health plan claim form utilized by participating providers; |
| (4) Methods for health maintenance organizations, as defined by § 27-41-2, and nonprofit |
| hospital or medical-service corporations, as defined by chapters 19 and 20 of title 27, to make |
| facility-specific data and other medical service-specific data available in reasonably consistent |
| formats to patients regarding quality and costs. This information would help consumers make |
| informed choices regarding the facilities and clinicians or physician practices at which to seek care. |
| Among the items considered would be the unique health services and other public goods provided |
| by facilities and clinicians or physician practices in establishing the most appropriate cost |
| comparisons; |
| (5) All activities related to contractual disclosure to participating providers of the |
| mechanisms for resolving health plan/provider disputes; |
| (6) The uniform process being utilized for confirming, in real time, patient insurance |
| enrollment status, benefits coverage, including co-pays and deductibles; |
| (7) Information related to temporary credentialing of providers seeking to participate in the |
| plan’s network and the impact of the activity on health plan accreditation; |
| (8) The feasibility of regular contract renegotiations between plans and the providers in |
| their networks; and |
| (9) Efforts conducted related to reviewing impact of silent PPOs on physician practices. |
| (e) To enforce the provisions of title 27 and title 42 as set forth in § 42-14-5(d). |
| (f) To provide analysis of the Rhode Island affordable health plan reinsurance fund. The |
| fund shall be used to effectuate the provisions of §§ 27-18.5-9 and 27-50-17. |
| (g) To analyze the impact of changing the rating guidelines and/or merging the individual |
| health insurance market, as defined in chapter 18.5 of title 27, and the small-employer health |
| insurance market, as defined in chapter 50 of title 27, in accordance with the following: |
| (1) The analysis shall forecast the likely rate increases required to effect the changes |
| recommended pursuant to the preceding subsection (g) in the direct-pay market and small-employer |
| health insurance market over the next five (5) years, based on the current rating structure and |
| current products. |
| (2) The analysis shall include examining the impact of merging the individual and small- |
| employer markets on premiums charged to individuals and small-employer groups. |
| (3) The analysis shall include examining the impact on rates in each of the individual and |
| small-employer health insurance markets and the number of insureds in the context of possible |
| changes to the rating guidelines used for small-employer groups, including: community rating |
| principles; expanding small-employer rate bonds beyond the current range; increasing the employer |
| group size in the small-group market; and/or adding rating factors for broker and/or tobacco use. |
| (4) The analysis shall include examining the adequacy of current statutory and regulatory |
| oversight of the rating process and factors employed by the participants in the proposed, new |
| merged market. |
| (5) The analysis shall include assessment of possible reinsurance mechanisms and/or |
| federal high-risk pool structures and funding to support the health insurance market in Rhode Island |
| by reducing the risk of adverse selection and the incremental insurance premiums charged for this |
| risk, and/or by making health insurance affordable for a selected at-risk population. |
| (6) The health insurance commissioner shall work with an insurance market merger task |
| force to assist with the analysis. The task force shall be chaired by the health insurance |
| commissioner and shall include, but not be limited to, representatives of the general assembly, the |
| business community, small-employer carriers as defined in § 27-50-3, carriers offering coverage in |
| the individual market in Rhode Island, health insurance brokers, and members of the general public. |
| (7) For the purposes of conducting this analysis, the commissioner may contract with an |
| outside organization with expertise in fiscal analysis of the private insurance market. In conducting |
| its study, the organization shall, to the extent possible, obtain and use actual health plan data. Said |
| data shall be subject to state and federal laws and regulations governing confidentiality of health |
| care and proprietary information. |
| (8) The task force shall meet as necessary and include its findings in the annual report, and |
| the commissioner shall include the information in the annual presentation before the house and |
| senate finance committees. |
| (h) To establish and convene a workgroup representing healthcare providers and health |
| insurers for the purpose of coordinating the development of processes, guidelines, and standards to |
| streamline healthcare administration that are to be adopted by payors and providers of healthcare |
| services operating in the state. This workgroup shall include representatives with expertise who |
| would contribute to the streamlining of healthcare administration and who are selected from |
| hospitals, physician practices, community behavioral health organizations, each health insurer, and |
| other affected entities. The workgroup shall also include at least one designee each from the Rhode |
| Island Medical Society, Rhode Island Council of Community Mental Health Organizations, the |
| Rhode Island Health Center Association, and the Hospital Association of Rhode Island. In any year |
| that the workgroup meets and submits recommendations to the office of the health insurance |
| commissioner, the office of the health insurance commissioner shall submit such recommendations |
| to the health and human services committees of the Rhode Island house of representatives and the |
| Rhode Island senate prior to the implementation of any such recommendations and subsequently |
| shall submit a report to the general assembly by June 30, 2024. The report shall include the |
| recommendations the commissioner may implement, with supporting rationale. The workgroup |
| shall consider and make recommendations for: |
| (1) Establishing a consistent standard for electronic eligibility and coverage verification. |
| Such standard shall: |
| (i) Include standards for eligibility inquiry and response and, wherever possible, be |
| consistent with the standards adopted by nationally recognized organizations, such as the Centers |
| for Medicare and & Medicaid Services; |
| (ii) Enable providers and payors to exchange eligibility requests and responses on a system- |
| to-system basis or using a payor-supported web browser; |
| (iii) Provide reasonably detailed information on a consumer’s eligibility for healthcare |
| coverage; scope of benefits; limitations and exclusions provided under that coverage; cost-sharing |
| requirements for specific services at the specific time of the inquiry; current deductible amounts; |
| accumulated or limited benefits; out-of-pocket maximums; any maximum policy amounts; and |
| other information required for the provider to collect the patient’s portion of the bill; |
| (iv) Reflect the necessary limitations imposed on payors by the originator of the eligibility |
| and benefits information; |
| (v) Recommend a standard or common process to protect all providers from the costs of |
| services to patients who are ineligible for insurance coverage in circumstances where a payor |
| provides eligibility verification based on best information available to the payor at the date of the |
| request of eligibility. |
| (2) Developing implementation guidelines and promoting adoption of the guidelines for: |
| (i) The use of the National Correct Coding Initiative code-edit policy by payors and |
| providers in the state; |
| (ii) Publishing any variations from codes and mutually exclusive codes by payors in a |
| manner that makes for simple retrieval and implementation by providers; |
| (iii) Use of Health Insurance Portability and Accountability Act standard group codes, |
| reason codes, and remark codes by payors in electronic remittances sent to providers; |
| (iv) The Uniformity in the processing of claims by payors; and the processing of |
| corrections to claims by providers and payors.; |
| (v) A standard payor-denial review process for providers when they request a |
| reconsideration of a denial of a claim that results from differences in clinical edits where no single, |
| common-standards body or process exists and multiple conflicting sources are in use by payors and |
| providers. |
| (vi) Nothing in this section, nor in the guidelines developed, shall inhibit an individual |
| payor’s ability to employ, and not disclose to providers, temporary code edits for the purpose of |
| detecting and deterring fraudulent billing activities. The guidelines shall require that each payor |
| disclose to the provider its adjudication decision on a claim that was denied or adjusted based on |
| the application of such edits and that the provider have access to the payor’s review and appeal |
| process to challenge the payor’s adjudication decision. |
| (vii) Nothing in this subsection shall be construed to modify the rights or obligations of |
| payors or providers with respect to procedures relating to the investigation, reporting, appeal, or |
| prosecution under applicable law of potentially fraudulent billing activities. |
| (3) Developing and promoting widespread adoption by payors and providers of guidelines |
| to: |
| (i) Ensure payors do not automatically deny claims for services when extenuating |
| circumstances make it impossible for the provider to obtain a preauthorization before services are |
| performed or notify a payor within an appropriate standardized timeline of a patient’s admission; |
| (ii) Require payors to use common and consistent processes and time frames when |
| responding to provider requests for medical management approvals. Whenever possible, such time |
| frames shall be consistent with those established by leading national organizations and be based |
| upon the acuity of the patient’s need for care or treatment. For the purposes of this section, medical |
| management includes prior authorization of services, preauthorization of services, precertification |
| of services, post-service review, medical-necessity review, and benefits advisory; |
| (iii) Develop, maintain, and promote widespread adoption of a single, common website |
| where providers can obtain payors’ preauthorization, benefits advisory, and preadmission |
| requirements; |
| (iv) Establish guidelines for payors to develop and maintain a website that providers can |
| use to request a preauthorization, including a prospective clinical necessity review; receive an |
| authorization number; and transmit an admission notification; |
| (v) Develop and implement the use of programs that implement selective prior |
| authorization requirements, based on stratification of health care healthcare providers’ |
| performance and adherence to evidence-based medicine with the input of contracted health care |
| healthcare providers and/or provider organizations. Such criteria shall be transparent and easily |
| accessible to contracted providers. Such selective prior authorization programs shall be available |
| when health care healthcare providers participate directly with the insurer in risk-based payment |
| contracts and may be available to providers who do not participate in risk-based contracts; |
| (vi) Require the review of medical services, including behavioral health services, and |
| prescription drugs, subject to prior authorization on at least an annual basis, with the input of |
| contracted health care healthcare providers and/or provider organizations. Any changes to the list |
| of medical services, including behavioral health services, and prescription drugs requiring prior |
| authorization, shall be shared via provider-accessible websites; |
| (vii) Improve communication channels between health plans, health care healthcare |
| providers, and patients by: |
| (A) Requiring transparency and easy accessibility of prior authorization requirements, |
| criteria, rationale, and program changes to contracted health care healthcare providers and |
| patients/health plan enrollees which may be satisfied by posting to provider-accessible and |
| member-accessible websites; and |
| (B) Supporting: |
| (I) Timely submission by health care healthcare providers of the complete information |
| necessary to make a prior authorization determination, as early in the process as possible; and |
| (II) Timely notification of prior authorization determinations by health plans to impacted |
| health plan enrollees, and health care healthcare providers, including, but not limited to, ordering |
| providers, and/or rendering providers, and dispensing pharmacists which may be satisfied by |
| posting to provider-accessible websites or similar electronic portals or services; and |
| (viii) Increase and strengthen continuity of patient care by: |
| (A) Defining protections for continuity of care during a transition period for patients |
| undergoing an active course of treatment, when there is a formulary or treatment coverage change |
| or change of health plan that may disrupt their current course of treatment and when the treating |
| physician determines that a transition may place the patient at risk; and for prescription medication |
| by allowing a grace period of coverage to allow consideration of referred health plan options or |
| establishment of medical necessity of the current course of treatment; |
| (B) Requiring continuity of care for medical services, including behavioral health services, |
| and prescription medications for patients on appropriate, chronic, stable therapy through |
| minimizing repetitive prior authorization requirements; and which for prescription medication shall |
| be allowed only on an annual review, with exception for labeled limitation, to establish continued |
| benefit of treatment; and |
| (C) Requiring communication between health care healthcare providers, health plans, and |
| patients to facilitate continuity of care and minimize disruptions in needed treatment which may be |
| satisfied by posting to provider-accessible websites or similar electronic portals or services; |
| (D) Continuity of care for formulary or drug coverage shall distinguish between FDA |
| designated interchangeable products and proprietary or marketed versions of a medication.; |
| (ix) Encourage health care providers and/or provider organizations and health plans to |
| accelerate use of electronic prior authorization technology, including adoption of national standards |
| where applicable; and |
| (x) For the purposes of subsections (h)(3)(v) through (h)(3)(x) of this section, the |
| workgroup meeting may be conducted in part or whole through electronic methods.. |
| (4) To provide a report to the house and senate, on or before January 1, 2017, with |
| recommendations for establishing guidelines and regulations for systems that give patients |
| electronic access to their claims information, particularly to information regarding their obligations |
| to pay for received medical services, pursuant to 45 C.F.R. § 164.524. |
| (5) No provision of § 42-14.5-3(h) this subsection (h) shall preclude the ongoing work of |
| the office of health insurance commissioner's administrative simplification task force, which |
| includes meetings with key stakeholders in order to improve, and provide recommendations |
| regarding, the prior authorization process. |
| (i) To issue an anti-cancer medication report. Not later than June 30, 2014, and annually |
| thereafter, the office of the health insurance commissioner (OHIC) shall provide the senate |
| committee on health and human services, and the house committee on corporations, with: (1) |
| Information on the availability in the commercial market of coverage for anti-cancer medication |
| options; (2) For the state employee’s health benefit plan, the costs of various cancer-treatment |
| options; (3) The changes in drug prices over the prior thirty-six (36) months; and (4) Member |
| utilization and cost-sharing expense. |
| (j) To monitor the adequacy of each health plan’s compliance with the provisions of the |
| federal Mental Health Parity Act, including a review of related claims processing and |
| reimbursement procedures. Findings, recommendations, and assessments shall be made available |
| to the public. |
| (k) To monitor the transition from fee-for-service and toward global and other alternative |
| payment methodologies for the payment for healthcare services. Alternative payment |
| methodologies should be assessed for their likelihood to promote access to affordable health |
| insurance, health outcomes, and performance. |
| (l) To report annually, no later than July 1, 2014, then biannually thereafter, on hospital |
| payment variation, including findings and recommendations, subject to available resources. |
| (m) Notwithstanding any provision of the general or public laws or regulation to the |
| contrary, provide a report with findings and recommendations to the president of the senate and the |
| speaker of the house, on or before April 1, 2014, including, but not limited to, the following |
| information: |
| (1) The impact of the current, mandated healthcare benefits as defined in §§ 27-18-48.1, |
| 27-18-60, 27-18-62, 27-18-64, similar provisions in chapters 19, 20 and 41 of title 27, and §§ 27- |
| 18-3(c), 27-38.2-1 et seq., or others as determined by the commissioner, on the cost of health |
| insurance for fully insured employers, subject to available resources; |
| (2) Current provider and insurer mandates that are unnecessary and/or duplicative due to |
| the existing standards of care and/or delivery of services in the healthcare system; |
| (3) A state-by-state comparison of health insurance mandates and the extent to which |
| Rhode Island mandates exceed other states benefits; and |
| (4) Recommendations for amendments to existing mandated benefits based on the findings |
| in (m)(1), (m)(2), and (m)(3) above. |
| (n) On or before July 1, 2014, the office of the health insurance commissioner, in |
| collaboration with the director of health and lieutenant governor’s office, shall submit a report to |
| the general assembly and the governor to inform the design of accountable care organizations |
| (ACOs) in Rhode Island as unique structures for comprehensive healthcare delivery and value- |
| based payment arrangements, that shall include, but not be limited to: |
| (1) Utilization review; |
| (2) Contracting; and |
| (3) Licensing and regulation. |
| (o) On or before February 3, 2015, the office of the health insurance commissioner shall |
| submit a report to the general assembly and the governor that describes, analyzes, and proposes |
| recommendations to improve compliance of insurers with the provisions of § 27-18-76 with regard |
| to patients with mental health and substance use disorders. |
| (p) To work to ensure the health insurance coverage of behavioral health care under the |
| same terms and conditions as other health care, and to integrate behavioral health parity |
| requirements into the office of the health insurance commissioner insurance oversight and health- |
| care transformation efforts. |
| (q) To work with other state agencies to seek delivery system improvements that enhance |
| access to a continuum of mental health and substance use disorder treatment in the state; and |
| integrate that treatment with primary and other medical care to the fullest extent possible. |
| (r) To direct insurers toward policies and practices that address the behavioral health needs |
| of the public and greater integration of physical and behavioral healthcare delivery. |
| (s) The office of the health insurance commissioner shall conduct an analysis of the impact |
| of the provisions of § 27-38.2-1(i) on health insurance premiums and access in Rhode Island and |
| submit a report of its findings to the general assembly on or before June 1, 2023. |
| (t) To undertake the analyses, reports, and studies contained in this section: |
| (1) The office shall hire the necessary staff and prepare a request for proposal for a qualified |
| and competent firm or firms to undertake the following analyses, reports, and studies: |
| (i) The firm shall undertake a comprehensive review of all social and human service |
| programs having a contract with or licensed by the state or any subdivision of the department of |
| children, youth and families (DCYF), the department of behavioral healthcare, developmental |
| disabilities and hospitals (BHDDH), the department of human services (DHS), the department of |
| health (DOH), and Medicaid for the purposes of: |
| (A) Establishing a baseline of the eligibility factors for receiving services; |
| (B) Establishing a baseline of the service offering through each agency for those |
| determined eligible; |
| (C) Establishing a baseline understanding of reimbursement rates for all social and human |
| service programs including rates currently being paid, the date of the last increase, and a proposed |
| model that the state may use to conduct future studies and analyses; |
| (D) Ensuring accurate and adequate reimbursement to social and human service providers |
| that facilitate the availability of high-quality services to individuals receiving home and |
| community-based long-term services and supports provided by social and human service providers; |
| (E) Ensuring the general assembly is provided accurate financial projections on social and |
| human service program costs, demand for services, and workforce needs to ensure access to entitled |
| beneficiaries and services; |
| (F) Establishing a baseline and determining the relationship between state government and |
| the provider network including functions, responsibilities, and duties; |
| (G) Determining a set of measures and accountability standards to be used by EOHHS and |
| the general assembly to measure the outcomes of the provision of services including budgetary |
| reporting requirements, transparency portals, and other methods; and |
| (H) Reporting the findings of human services analyses and reports to the speaker of the |
| house, senate president, chairs of the house and senate finance committees, chairs of the house and |
| senate health and human services committees, and the governor. |
| (2) The analyses, reports, and studies required pursuant to this section shall be |
| accomplished and published as follows and shall provide: |
| (i) An assessment and detailed reporting on all social and human service program rates to |
| be completed by January 1, 2023, including rates currently being paid and the date of the last |
| increase; |
| (ii) An assessment and detailed reporting on eligibility standards and processes of all |
| mandatory and discretionary social and human service programs to be completed by January 1, |
| 2023; |
| (iii) An assessment and detailed reporting on utilization trends from the period of January |
| 1, 2017, through December 31, 2021, for social and human service programs to be completed by |
| January 1, 2023; |
| (iv) An assessment and detailed reporting on the structure of the state government as it |
| relates to the provision of services by social and human service providers including eligibility and |
| functions of the provider network to be completed by January 1, 2023; |
| (v) An assessment and detailed reporting on accountability standards for services for social |
| and human service programs to be completed by January 1, 2023; |
| (vi) An assessment and detailed reporting by April 1, 2023, on all professional licensed |
| and unlicensed personnel requirements for established rates for social and human service programs |
| pursuant to a contract or established fee schedule; |
| (vii) An assessment and reporting on access to social and human service programs, to |
| include any wait lists and length of time on wait lists, in each service category by April 1, 2023; |
| (viii) An assessment and reporting of national and regional Medicaid rates in comparison |
| to Rhode Island social and human service provider rates by April 1, 2023; |
| (ix) An assessment and reporting on usual and customary rates paid by private insurers and |
| private pay for similar social and human service providers, both nationally and regionally, by April |
| 1, 2023; and |
| (x) Completion of the development of an assessment and review process that includes the |
| following components: eligibility; scope of services; relationship of social and human service |
| provider and the state; national and regional rate comparisons and accountability standards that |
| result in recommended rate adjustments; and this process shall be completed by September 1, 2023, |
| and conducted biennially hereafter. The biennial rate setting shall be consistent with payment |
| requirements established in § 1902(a)(30)(A) of the Social Security Act, 42 U.S.C. § |
| 1396a(a)(30)(A), and all federal and state law, regulations, and quality and safety standards. The |
| results and findings of this process shall be transparent, and public meetings shall be conducted to |
| allow providers, recipients, and other interested parties an opportunity to ask questions and provide |
| comment beginning in September 2023 and biennially thereafter. |
| (3) In fulfillment of the responsibilities defined in subsection (t), the office of the health |
| insurance commissioner shall consult with the Executive Office of Health and Human Services. |
| (u) Annually, each department (namely, EOHHS, DCYF, DOH, DHS, and BHDDH) shall |
| include the corresponding components of the assessment and review (i.e., eligibility; scope of |
| services; relationship of social and human service provider and the state; and national and regional |
| rate comparisons and accountability standards including any changes or substantive issues between |
| biennial reviews) including the recommended rates from the most recent assessment and review |
| with their annual budget submission to the office of management and budget and provide a detailed |
| explanation and impact statement if any rate variances exist between submitted recommended |
| budget and the corresponding recommended rate from the most recent assessment and review |
| process starting October 1, 2023, and biennially thereafter. |
| (v) The general assembly shall appropriate adequate funding as it deems necessary to |
| undertake the analyses, reports, and studies contained in this section relating to the powers and |
| duties of the office of the health insurance commissioner. |
| SECTION 2. This act shall take effect upon passage. |
| ======== |
| LC001062/SUB A |
| ======== |